Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Change-To-Inventory" stands at -1.49 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 12/31/2023.
Johnson & Johnson's third quarter result of -0.748 Billion USD for the item "Change To Inventory" represents a decrease of -46.67 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of -0.748 Billion USD for the item "Change To Inventory" represents a decrease of -150.17 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of -1.49 Billion USD for the item "Change To Inventory" represents a decrease of -42.97 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.58 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.58 Billion United States Dollars.
The 3 year change is 0.453 Billion United States Dollars.
The 5 year change is -0.857 Billion United States Dollars.
The 10 year change is -0.753 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change To Inventory | 905,699,262,464.00 |
![]() | AbbVie Inc - Change To Inventory | 399,570,305,024.00 |
![]() | Roche Holding AG - Change To Inventory | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change To Inventory | 280,205,508,085.11 |
![]() | Novartis AG - Change To Inventory | 255,096,620,580.91 |